Novartis and GlaxoSmithKline (GSK), two of the world’s leading drug makers, agree to exchange some assets and combine their consumer healthcare units.

Source: http://www.bbc.co.uk/news/business-27107416#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa

This entry was posted on Tuesday, April 22nd, 2014 at 1:49 am and is filed under Business. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.